YEHUDA MICHAEL RICE - 01 Jan 2023 Form 3 Insider Report for Vascular Biogenics Ltd. (VBLT)

Role
Director
Signature
/s/ Samuel Backenroth, Attorney-in-Fact
Issuer symbol
VBLT
Transactions as of
01 Jan 2023
Transactions value $
$0
Form type
3
Filing time
03 Jan 2023, 20:03:16 UTC
Previous filing
23 Jun 2022
Next filing
31 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VBLT Stock Option (Right to Buy) 01 Jan 2023 Ordinary Shares 87K $2.20 Direct F1
holding VBLT Stock Option (Right to Buy) 01 Jan 2023 Ordinary Shares 35.5K $2.31 Direct F2
holding VBLT Stock Option (Right to Buy) 01 Jan 2023 Ordinary Shares 23.6K $2.12 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 10/19/21 under the Issuer's Employee Share Ownership and Option Plan (2014) (the "2014 Plan") with 25% of the shares underlying these options vesting on October 19, 2022 (the one year anniversary of the grant date), and the remainder vesting quarterly thereafter for three years such that they are vested in full on the four-year anniversary of the grant date.
F2 These options were granted on 12/07/21 under the 2014 Plan and vest over two years commencing on the grant date such that 50% vest on the first anniversary of the date of grant and the remainder vest quarterly thereafter for one year such that they are vested in full on the two-year anniversary of the grant date.
F3 These options were granted on 01/02/22 under the 2014 Plan and vest over two years commencing on the grant date such that 50% vest on the first anniversary of the date of grant and the remainder vest quarterly thereafter for one year such that they are vested in full on the two-year anniversary of the grant date.

Remarks:

Exhibit 24 - Power of Attorney